Buys
Open market- Shares
- Avg price
- Total value
Richard Daniell - EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD
Insider Transactions and Holdings
- Role
- EVP, Europe Commercial
- Issuer symbol
- TEVA on NYSE, TEVJF on OTC
- Entity type
- Individual
- Source evidence
- Open source filing history
Identity
1 fact
SEC evidence
1 fact
Richard Daniell - trading volume in the past year for TEVA PHARMACEUTICAL INDUSTRIES LTD
Sells
Open market- Shares
- -383,093
- Avg price
- $31.53
- Total value
- -$12,078,289
Net
Past year- Shares
- -383,093
- Share %
- -100%
- Total value
- -$12,078,289
Holdings reported by Richard Daniell for TEVA PHARMACEUTICAL INDUSTRIES LTD
Form 4 holding
EVP, Europe Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Ordinary Shares
- Shares / value
- 55,755
- Estimated value
- $1,973,727
- Report date
- 05 May 2026
- Price
- $35.40
- Ownership
- Direct
Form 4 holding
EVP, Europe Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Restricted Share Units
- Shares / value
- 51,887
- Estimated value
- Report date
- 05 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
EVP, Europe Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Stock Options (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 09 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transactions reported by Richard Daniell for TEVA PHARMACEUTICAL INDUSTRIES LTD
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.